Table 5.
Evaluation parameter | CA19-9 |
---|---|
Sensitivity | 85.7% |
Specificity | 94.1% |
Positive predictive value | 6/7 (85.7%) |
Negative predictive value | 17/18 (94.4%) |
HPD: hyperprogressive disease.
Evaluation parameter | CA19-9 |
---|---|
Sensitivity | 85.7% |
Specificity | 94.1% |
Positive predictive value | 6/7 (85.7%) |
Negative predictive value | 17/18 (94.4%) |
HPD: hyperprogressive disease.